Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With Congestive Heart Failure (CHF) and Renal Impairment

Trial Profile

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With Congestive Heart Failure (CHF) and Renal Impairment

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2010

At a glance

  • Drugs Furosemide; Rolofylline
  • Indications Heart failure; Renal impairment
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Mar 2010 'Merck and Co' added as trial sponsor as reported by ClinicalTrials.gov.
    • 06 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top